awmsg logo



ivermectin (Soolantra®)


Reference No. 1627

Publication date:
01/04/2016


Appraisal information

ivermectin (Soolantra®) 10 mg/g cream


Company: Galderma (UK) Ltd
BNF category: Skin
NMG meeting date: 20/01/2016
AWMSG meeting date: 24/02/2016
   
   
Submission Type: Full Submission
Status: Recommended
Advice No: 0216
Ministerial ratification: 24/03/2016

Current Progress


Submission
received
NMG
meeting
AWMSG
meeting
Ministerial
Ratification

AWMSG advice

Ivermectin (Soolantra®) is recommended as an option for use within NHS Wales for the topical treatment of inflammatory lesions of rosacea (papulopustular) in adult patients.
Final Appraisal Recommendation (FAR)
Download
AWMSG Secretariat Appraisal Report (ASAR)
Download
Clinical Expert (CE) Summary
Download